Novavax
NVAX
#5392
Rank
โ‚น141.75 B
Marketcap
โ‚น862.04
Share price
-1.43%
Change (1 day)
30.46%
Change (1 year)

Market capitalization of Novavax (NVAX)

Market cap: โ‚น141.75 Billion

As of May 2026 Novavax has a market cap of โ‚น141.75 Billion. This makes Novavax the world's 5392th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novavax from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น141.75 B42.27%
2025โ‚น99.63 B-12.44%
2024โ‚น113.78 B139.7%
2023โ‚น47.46 B-34.36%
2022โ‚น72.31 B-91.02%
2021โ‚น805.14 B55.09%
2020โ‚น519.15 B5553.97%
2019โ‚น9.18 B-81.44%
2018โ‚น49.46 B66.42%
2017โ‚น29.72 B27.98%
2016โ‚น23.22 B-84.57%
2015โ‚น150.52 B67.7%
2014โ‚น89.76 B36%
2013โ‚น66.00 B331.1%
2012โ‚น15.30 B99.78%
2011โ‚น7.66 B-36.62%
2010โ‚น12.09 B-2.3%
2009โ‚น12.37 B96.94%
2008โ‚น6.28 B-22.39%
2007โ‚น8.09 B-27.85%
2006โ‚น11.22 B18.33%
2005โ‚น9.48 B69.81%
2004โ‚น5.58 B-41.12%
2003โ‚น9.48 B204.61%
2002โ‚น3.11 B-80.35%
2001โ‚น15.84 B80.73%
2000โ‚น8.76 B136.43%
1999โ‚น3.70 B271.02%
1998โ‚น0.99 B-57.65%
1997โ‚น2.36 B79.13%
1996โ‚น1.31 B

End of Day market cap according to different sources

On May 18th, 2026 the market cap of Novavax was reported to be:

โ‚น141.75 Billion
by Nasdaq info icon info icon
โ‚น141.75 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
โ‚น27.472 T 19,280.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น13.936 T 9,731.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น27.534 T 19,324.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น9.739 T 6,771.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚น173.35 B 22.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น228.97 B 61.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น12.70 B-91.04%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚น3.32 B-97.66%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น220.07 B 55.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น40.49 B-71.43%๐Ÿ‡บ๐Ÿ‡ธ USA